Targeting prostaglandin E₂ EP1 receptors prevents seizure-associated P-glycoprotein up-regulation

Medicine and Dentistry

• Upregulation 100%
• Epileptic Seizure 100%
• ABC Transporter Subfamily B 100%
• Prostaglandin E Receptor 1 100%
• Anticonvulsant 30%
• Epilepsy 20%
• Blood Brain Barrier 20%
• Receptor Antagonist 20%
• Phenobarbital 20%
• Combination Therapy 10%
• Therapeutic Procedure 10%
• Signal Transduction 10%
• Drug 10%
• Chemotherapeutic Agent 10%
• Receptor 10%
• Drive 10%
• Granule Cell 10%
• Low Drug Dose 10%
• Effusion 10%
• Chloride 10%
• Central Nervous System Disease 10%
• Propane 10%
• Pilocarpine 10%
• Status Epilepticus 10%
• Hydrazide 10%
• Oxazepine Derivative 10%
• Kindling 10%
• Drug Efficacy 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Seizure 100%
• P-Glycoprotein 100%
• Prostaglandin E Receptor 1 100%
• Anticonvulsive Agent 30%
• Epilepsy 20%
• Blood-Brain Barrier 20%
• Receptor Antagonist 20%
• Phenobarbital 20%
• Drug 10%
• Animal 10%
• Receptor 10%
• Rat 10%
• Acid 10%
• Chloride 10%
• Hydrazide 10%
• Effusion 10%
• Central Nervous System Disease 10%
• Epileptic State 10%
• Propane 10%
• Oxazepine Derivative 10%
• Pilocarpine 10%

Neuroscience

• Seizure 100%
• ABC Transporter Subfamily B 100%
• Anticonvulsant 20%
• Epilepsy 20%
• Blood Brain Barrier 20%
• Receptor Antagonist 20%
• Phenobarbital 20%
• Cell Signaling 10%
• Nervous System Disorder 10%
• Brain 10%
• Granule Cell 10%
• Central Nervous System 10%
• Anticonvulsant 10%
• Chloride 10%
• Kindling 10%
• Status Epilepticus Model 10%
• Pilocarpine 10%